Comparison between Shimizu (OTCMKTS: SHMUY) and Orion Oyj (OTCMKTS: ORINY)

0

Shimizu (OTCMKTS:SHMUY – Get Rating) and Orion Oyj (OTCMKTS:ORINY – Get Rating) are both construction companies, but which is the best investment? We’ll compare the two companies based on their dividend strength, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Analyst Notes

This is a breakdown of the current ratings and recommendations for Shimizu and Orion Oyj, as reported by MarketBeat.com.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Shimizu 0 2 0 0 2.00
Orion Oyj 0 0 0 0 N / A

Volatility and risk

Shimizu has a beta of 0.58, suggesting its stock price is 42% less volatile than the S&P 500. Comparatively, Orion Oyj has a beta of 0.69, suggesting its stock price is 31% less volatile than the S&P 500.

Benefits and evaluation

This table compares the revenue, earnings per share and valuation of Shimizu and Orion Oyj.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Shimizu $13.21 billion N / A $425.06 million $2.24 9.49
Orion Oyj $1.23 billion 4.58 $229.29 million $0.81 24.69

Shimizu has higher revenue and profit than Orion Oyj. Shimizu is trading at a lower price-to-earnings ratio than Orion Oyj, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares the net margins, return on equity and return on assets of Shimizu and Orion Oyj.

Net margins Return on equity return on assets
Shimizu 3.18% 3.98% 1.66%
Orion Oyj 18.71% 27.42% 17.56%

Dividends

Shimizu pays an annual dividend of $0.30 per share and has a dividend yield of 1.4%. Orion Oyj pays an annual dividend of $0.49 per share and has a dividend yield of 2.5%. Shimizu pays 13.4% of its profits as a dividend. Orion Oyj pays 60.5% of its profits as a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings over the next few years.

Summary

Orion Oyj beats Shimizu on 6 out of 10 factors compared between the two stocks.

About Shimizu (Get an assessment)

Shimizu Corporation engages in construction, civil engineering, machinery and other construction work in Japan. It is also involved in research, planning, study, evaluation, diagnosis, soil analysis, surveying, design, supervision, management and advice related to regional, urban, ocean, space, resources and energy, as well as construction work. and improvement of the environment; and purchase, sale, rental, brokerage, management, appraisal and consulting of real estate. The company builds, rents, sells and maintains residential houses and other buildings; plans, constructs, owns, maintains and operates public office buildings, roads, ports, airports and parks, as well as educational and cultural, medical and social, water supply and sanitation facilities; generates and supplies electricity and heat; undertakes purification works; collects, disposes and reuses waste; and designs, installs, rents, sells and maintains the building information communication and management system. It also deals with the cultivation, production, management, sale and consultation of agricultural and marine products and forestry work; maintenance and upkeep, security and cleaning of buildings, equipment and machines; and the design, manufacture, sale, rental and brokerage of construction machinery and materials, concrete and wood products, furniture and interior fittings. The company offers industrial property, copyrights and computer software; pharmaceuticals, medical care materials and medical machinery and equipment; and advertising, publishing, printing, pictures and other information media, business events, inland transportation, warehouse, distribution center, insurance and travel agency, labor supply, loan, warranty and factoring services. It is also responsible for the management and advice of sports, hotel, catering, care and resort facilities. The company was founded in 1804 and is based in Tokyo, Japan.

About Orion Oyj (Get an assessment)

Orion Oyj develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedatives; Stalevo and Comtess/Comtan for Parkinson’s disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, and the medicines Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler and Buventol Easyhaler for the treatment of asthma and chronic obstructive pulmonary disease. The Company also offers veterinary medicines including Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo and Tessie; and APIs for generic and proprietary drugs, as well as contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various service providers and healthcare professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, health centers, clinics and laboratories, as well as consumers with pets. . Orion Oyj has partnered with Propeller Health to connect the Easyhaler(R) portfolio of products for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop novel bispecific cancer treatments. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.



Get news and reviews for Shimizu Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Shimizu and related companies with MarketBeat.com’s free daily email newsletter.

Share.

Comments are closed.